Jesus Berdeja, MD on BCMA CAR-T Therapy JNJ-4528: How Does This Differ? @SarahCannonDocs #ASCO2020 #ASCO

Jesus Berdeja, MD of Sarah Cannon Research Institute discusses the BCMA CAR-T therapy JNJ-4528 in pretreated patients with multiple myeloma.

Read here: https://meetinglibrary.asco.org/record/186155/abstract